Changes in Bone Microarchitecture and Inflammatory Cytokines After Cure of Chronic Hepatitis C Infection With Direct-Acting Antiviral Therapy - Summary - MDSpire

Changes in Bone Microarchitecture and Inflammatory Cytokines After Cure of Chronic Hepatitis C Infection With Direct-Acting Antiviral Therapy

  • By

  • Vincent Lo Re

  • Dean M Carbonari

  • Craig W Newcomb

  • Jessie Torgersen

  • Erica J Weinstein

  • Shanae M Smith

  • Katherine L Brecker

  • X Sherry Liu

  • Jay R Kostman

  • Stacey Trooskin

  • Rebecca A Hubbard

  • Joshua F Baker

  • Babette S Zemel

  • Mary B Leonard

  • September 15, 2025

  • 0 min

Share

Objective:

To evaluate changes in inflammatory cytokines and bone measurements following cure of chronic hepatitis C with direct-acting antivirals (DAAs), specifically assessing post-treatment outcomes.

Key Findings:
  • No significant differences in bone microarchitecture changes between cured HCV participants and controls, indicating no improvement.
  • Cured HCV participants showed significant decreases in IL-18 and TNF-α levels compared to controls.
  • No significant change in IL-6 levels between groups.
Interpretation:

Curing HCV with DAAs does not appear to improve bone microarchitecture but is associated with reduced levels of certain inflammatory cytokines, which may have broader health implications.

Limitations:
  • Small sample size may limit generalizability.
  • Short follow-up period of 18 months may not capture long-term effects.
  • Potential biases in participant selection could affect results.
Conclusion:

While DAA therapy reduces inflammatory cytokines, it does not significantly improve bone microarchitecture in individuals cured of chronic HCV.

Original Source(s)

Related Content